Nutra Pharma Corp (NPHC) stock
NPHCOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
$0.00+0.00 (0.00%)
Close on Oct 19, 2026Market cap $806.69KP/E –Yield –
Nutra Pharma operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Nutra Pharma's operating cash flow for the twelve months ending Jun 30, 2026 was -$1.05M. For fiscal 2025 it was -$1.16M. The highest annual figure on record is -$148.13K in fiscal 2014.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$1.16M | – |
| FY2024 | Dec 31, 2024 | -$423.96K | – |
| FY2023 | Dec 31, 2023 | -$550.04K | – |
| FY2022 | Dec 31, 2022 | -$762.43K | – |
| FY2021 | Dec 31, 2021 | -$1.74M | – |
| FY2020 | Dec 31, 2020 | -$878.09K | – |
| FY2019 | Dec 31, 2019 | -$743.66K | – |
| FY2018 | Dec 31, 2018 | -$999.95K | – |
| FY2017 | Dec 31, 2017 | -$1.14M | – |
| FY2016 | Dec 31, 2016 | -$1.36M | – |
| FY2015 | Dec 31, 2015 | -$1.02M | – |
| FY2014 | Dec 31, 2014 | -$148.13K | – |
| FY2013 | Dec 31, 2013 | -$531.04K | – |
| FY2012 | Dec 31, 2012 | -$721.24K | – |
| FY2011 | Dec 31, 2011 | -$1.89M | – |
| FY2010 | Dec 31, 2010 | -$1.36M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$251.22K | – |
| Q1 FY2026 | Mar 31, 2026 | -$327.79K | – |
| Q4 FY2025 | Dec 31, 2025 | -$219.82K | – |
| Q3 FY2025 | Sep 30, 2025 | -$250.77K | -1414.8% |
| Q2 FY2025 | Jun 30, 2025 | -$288.37K | – |
| Q1 FY2025 | Mar 31, 2025 | -$405.01K | – |
| Q4 FY2024 | Dec 31, 2024 | -$178.21K | – |
| Q3 FY2024 | Sep 30, 2024 | $19.07K | – |
| Q2 FY2024 | Jun 30, 2024 | -$93.62K | – |
| Q1 FY2024 | Mar 31, 2024 | -$171.20K | – |
| Q4 FY2023 | Dec 31, 2023 | -$186.23K | – |
| Q3 FY2023 | Sep 30, 2023 | -$84.19K | – |
| Q2 FY2023 | Jun 30, 2023 | -$186.84K | – |
| Q1 FY2023 | Mar 31, 2023 | -$92.78K | – |
| Q4 FY2022 | Dec 31, 2022 | -$54.03K | – |
| Q3 FY2022 | Sep 30, 2022 | -$165.34K | – |
| Q2 FY2022 | Jun 30, 2022 | -$284.83K | – |
| Q1 FY2022 | Mar 31, 2022 | -$258.23K | – |
| Q4 FY2021 | Dec 31, 2021 | -$233.68K | – |
| Q3 FY2021 | Sep 30, 2021 | -$412.92K | – |
| Q2 FY2021 | Jun 30, 2021 | -$503.54K | – |
| Q1 FY2021 | Mar 31, 2021 | -$594.33K | – |
| Q4 FY2020 | Dec 31, 2020 | -$352.82K | – |
| Q3 FY2020 | Sep 30, 2020 | -$137.05K | – |
| Q2 FY2020 | Jun 30, 2020 | -$172.65K | – |
| Q1 FY2020 | Mar 31, 2020 | -$215.56K | – |
| Q4 FY2019 | Dec 31, 2019 | -$308.72K | – |
| Q3 FY2019 | Sep 30, 2019 | -$151.24K | – |
| Q2 FY2019 | Jun 30, 2019 | -$192.20K | – |
| Q1 FY2019 | Mar 31, 2019 | -$91.50K | – |
| Q4 FY2018 | Dec 31, 2018 | -$136.05K | – |
| Q3 FY2018 | Sep 30, 2018 | -$162.93K | – |
| Q2 FY2018 | Jun 30, 2018 | -$352.66K | – |
| Q1 FY2018 | Mar 31, 2018 | -$348.31K | – |
| Q4 FY2017 | Dec 31, 2017 | -$226.39K | – |
| Q1 FY2017 | Mar 31, 2017 | -$371.48K | – |
| Q2 FY2016 | Jun 30, 2016 | -$283.14K | – |
| Q1 FY2016 | Mar 31, 2016 | -$265.73K | – |
See a number that looks wrong?